TY - JOUR
T1 - Pure red cell aplasia - A rare disease with multiple causes
AU - Djaldetti, M.
AU - Blay, A.
AU - Bergman, M.
AU - Salman, H.
AU - Bessler, H.
PY - 2003/10/1
Y1 - 2003/10/1
N2 - Pure red cell aplasia (PRCA) is a relatively rare disease although multiple factors are implied in the pathogenesis of its development. A slow progressive normocytic-normochromic anemia and reticulocytopenia, without leukopenia and thrombocytopenia in a patient who, except pallor, does not show abnormal findings on physical examination, should arise the suspicion that he has PRCA. Search for underlying diseases or infections and intake of drugs may help for the establishment of the diagnosis of acquired PRCA. Lack of erythroblasts in the bone marrow with normal development of the other hemopoietic series, as well as high level of serum erythropoietin are important clues for the diagnosis. Elimination of potentially causative factors, administration of immunosuppressive agents and/or recombinant erythropoietin, preferably epoetin beta, may induce remission and complete recovery.
AB - Pure red cell aplasia (PRCA) is a relatively rare disease although multiple factors are implied in the pathogenesis of its development. A slow progressive normocytic-normochromic anemia and reticulocytopenia, without leukopenia and thrombocytopenia in a patient who, except pallor, does not show abnormal findings on physical examination, should arise the suspicion that he has PRCA. Search for underlying diseases or infections and intake of drugs may help for the establishment of the diagnosis of acquired PRCA. Lack of erythroblasts in the bone marrow with normal development of the other hemopoietic series, as well as high level of serum erythropoietin are important clues for the diagnosis. Elimination of potentially causative factors, administration of immunosuppressive agents and/or recombinant erythropoietin, preferably epoetin beta, may induce remission and complete recovery.
UR - http://www.scopus.com/inward/record.url?scp=0141892774&partnerID=8YFLogxK
U2 - 10.1016/j.biopha.2003.08.001
DO - 10.1016/j.biopha.2003.08.001
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.shortsurvey???
AN - SCOPUS:0141892774
SN - 0753-3322
VL - 57
SP - 326
EP - 332
JO - Biomedicine and Pharmacotherapy
JF - Biomedicine and Pharmacotherapy
IS - 8
ER -